Genes from the 20q13 amplicon and their uses

Details Genes from the 20q13 amplicon and their uses Genes from the 20q13 amplicon and their uses

1997-01-17

2008-11-25

Helms, Larry R. (Department: 1642)

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

Involving nucleic acid

C436S501000, C436S504000, C436S813000, C536S023100, C536S024300, C536S024310

Reexamination Certificate

active

07455964

ABSTRACT:
The present invention relates to cDNA sequences from a region of amplification on chromosome 20 associated with disease. The sequences can be used in hybridization methods for the identification of chromosomal abnormalities associated with various diseases. The sequences can also be used for treatment of diseases.

REFERENCES:
patent: 5472842 (1995-12-01), Stokke et al.
patent: 5633365 (1997-05-01), Stokke et al.
patent: 5892010 (1999-04-01), Gray et al.
patent: 6808878 (2004-10-01), Gray et al.
patent: 7049424 (2006-05-01), Gray et al.
patent: 2006/0292591 (2006-12-01), Gray et al.
patent: 774736 (2004-10-01), None
patent: 0 430 402 (1991-05-01), None
patent: 430402 (1991-06-01), None
patent: 0 533 006 (1993-03-01), None
patent: 0 571 911 (1993-12-01), None
patent: 0 960197 (1999-12-01), None
patent: 93/24514 (1993-12-01), None
patent: WO 93/24514 (1993-12-01), None
patent: WO 93/25671 (1993-12-01), None
patent: WO 94/01548 (1994-01-01), None
patent: WO 94/001548 (1994-12-01), None
patent: WO 95/09929 (1995-04-01), None
patent: 95/14772 (1995-06-01), None
patent: 95/334480 (1995-12-01), None
patent: WO 97/14811 (1997-04-01), None
patent: WO 98/002539 (1998-01-01), None
Zakert-Houri, R. et al. Nature 306: 594-597, 1983.
Morris, CM et al. Blood 78(4):1078-1084, 1991.
Tanner et al. Cancer Res. 54: 4257-4260, 1994.
Kallioniemi, A et al. PMAS, USA, 91: 2156-2160, 1994.
Le, F. J. Affective Disorders 32(3): 187-195, 1994.
Montesano, R et al, 1996 Intl J Cancer, 69(3): 225-235.
Burmer, GC et al, 1991, Environmental Health perspectives, 93: 27-31.
Busken, C et al, Digestive Disease Week Abstracts and Itinerary Planner, 2003, abstract No:850.
Tanner et al. Increased Copy Number on 20q13 in Breast Cancer: Defining the Critical Region and Exclusion of Candidates Genes. Cancer Research. Aug. 15, 1994, vol. 54, pp. 4257-4260.
Gyapay et al. The 1993-1994 genethon human genetic linkage map. Nature Genetics. Jun. 1994, vol. 7, pp. 246-339.
Datebase EST-STS on MPsrch Accession No. G08049, Murray et al. Cooperative human linkage center Aug. 8, 1995.
Brown et al., 1995,J. Biol. Chem.279(49):29236-29243.
Brown et al., 1995,Protein Expr. Purif.6(1):63-71.
J.N. Lucas et al. “Translocations between two specific human chromosomes detected by three-color chromosome painting;”Cytogenet Cell Genetvol. 62 pp. 11-12 (1993).
Annika Lindblom et al. “Deletions on Chromosome 16 in Primary Familial Breast Carcinomas Are Associated with Development of Distant Metatases”Cancer Researchvol. 53, pp. 3707-3711, Aug. 15, 1993.
Ulf S.R.. Bergerheim et al. “Deletion Mapping of Chromosomes 8, 10, and 16 in Human Prostatic Carcinoma”Genes. Chromosomes&Cancervol. 3, pp. 215-220 (1991).
Elisabeth Blennow et al. “Complete characterization of a large marker chromosome by reverse and forward chromosome painting”m Genet(1992) vol. 90, pp. 371-374. Received: Jun. 15, 1992/Revised: Jul. 6, 1992.
Stefan Joos et al. “Detection of amplified DNA sequences by reverse chromosome painting using genomic tumor DNA as probe”m Genet(1993) vol. 90, pp. 584-589. Received: Oct. 30, 1993.
Anne Kallioniemi et al. “Comparative Genomic Hybridization for Molecular Cytogenetic Analysis of Solid Tumors”Sciencevol. 258, Oct. 30, 1992 pp. 818-821.
Peter Lichter et al. “High-Resolution Mapping of Human Chromosome 11 by in Situ Hybridization with Cosmid Clones”Sciencevol. 247 Jan. 5, 1990 pp. 64-69.
Anne Kallioniemi et al. “ERBB2 amplification in breast cancer analyzed by fluorescence in situ hybridization”Proc. Acad. Nat. Sci., USA, 89:5321-5325 (1992).
Pinkel et al. “Fluorescence in situ hybridization with human chromosome-specific libraries: Detection of trisomy 21 and translocations of chromosome 4”Proc. Acad. Nat. Sci, USA, 85:9138-9142 (1988).
ATCC/NIH Repository Catalogue, 1992, p. 113-114.
Strokke et al.Genomics26:134 (1995).
Beeler et al. (1994) “Prokaryotic Expression Cloning of a Novel Human Tyrosine Kinase.” Molecular and Cellular Biology, 14:982-988.
Lathe (1985) J. Mol. Biol. 183:1-12.
Gorbulev, Valentin, et al. “Organizational and chromosomal localization of the gene for the human bombesin receptor subtype expressed in pregnant uterus”FEBS Letters340:260-264 (1994).
Horowitz, Mia, et al. “The Human Glucocerebrosidase Gene and Pseudogene: Structure and Evolution”,Genomics4:87-96 (1989).
Morris, Christine M., et al. “Entire ABL Gene is Joined With 5′ -BCRin Some Patients With Philadelphia-Positive Leukemia”,Blood78(4) :1078-1084 (1991).
Pawlak, Andre, et al. “Characterization of a Large Population of mRNAs from Human Testis”,Genomics26:151-158 (1995).
Okubo, Kousaku, et al. “An Expression Profile of Active Genes in Human Colonic Mucosa”,DNA Research1:37-45 (1994).
Short, Jay M., et al. “λ ZAP: a bacteriophage λ expression vector with in vivo excision properties”,Nucleic Acids Research16(15) :7583-7600.
Tanner et al. (1995) “Amplification of Chromosomal Region 20q13 in Invasive Breast Cancer: Prognostic Implication.”Clinical Cancer Research, 1: 1455-1461.
Accession No. 16954 Jun. 29,1995.
Accession No. G11697 Oct. 19, 1995.
Accession No. G25553 May 31, 1996.
Accession No. G27410 Jun. 28, 1996.
Accession No. H12950 Jun. 27, 1995.
Accession No. H16953 Jun. 29, 1995.
Accession No. N32481 Jan. 10, 1996.
Accession No. H40682 Aug. 16, 1995.
Accession No. N70546 Mar. 14, 1996.
Accession No. N78571 Mar. 29, 1996.
Accession No. N93893 Apr. 5, 1996.
Accession No. Q63862 (Jan. 29, 1995).
Genbank Accession No. N78581 (Mar. 29, 1996) Hillier et al.
Genbank Accession No. WO5407 Hillier et al.
Genbank Accession No. X17105 (Nov. 9, 1995) Bergsman et al.
Benz et al., Journal of the National Cancer Institude, Nov. 1989, 81 (22):1704-1709.
Berns et al., Gene, 1995, 159:11-18.
Borg et al., Oncogene, 1991, 6:137-143.
Brinkmann et al., Genome Research, 1996, 6:187-194.
Collins, PNAS 95:8703 (1998) cited in P002X2C1.
Courjal et al., British Journal of Cancer, 1996, 74:1984-1989.
Deng et al., Breast Cancer Res Treat, 1996;40(3):271-81.
Dutrillaux et al., Cancer Genet Cytogenet, 1990, 49:203-207.
Fu et al., EMBO J. 1996 Aug. 15;15(16):4392-401.
Guan et al., Advances in Brief, Aug. 1996, 56:3446-3450.
Kallioniemi et al., Proc Natl Acad Sci USA, 1994 Mar. 15;91(6):2156-60.
Muleris et al., Genes Chromosomes Cancer, 1994 Jul; 10(3):160-70 (Abstract only).
Reznikoff et al., Genes & Development, Sep. 1994, 8(18):2227-2240.
Smith et al., Breast Cancer Research and Treatment, May 1991, 18(1):s51-s54.
Tanner, Cancer Research 56: 3441-3445 (1996).
Van de Vijver et al., Biochimica et Biophysica Acta, 1991, 1072:33-50.
Australian Office Action dated Sep. 1, 1999 issued in AU3602097.
Canadian Office Action dated Jan. 7, 2004 issued in CA2257821.
Canadian Office Action dated Dec. 7, 2005 issued in CA2257821.
European Office Action dated May 14, 2004 issued in EP 97 93 6212.
Japanese Office Action dated Nov. 13, 2007 issued in JP 10-506264.
PCT International Search Report dated Jan. 30, 1997 issued in PCT/US96/16085.
US Office Action dated Jul. 24, 2007 issued in 11/349066.
US Office Action dated Apr. 21, 1997 issued in 08/680,395.
US Office Action dated Jan. 21, 1998 issued in 08/680,395.
US Notice of Allowance and Issued Claims dated Sep. 28, 1998 issued in 08/680,395.
US Office Action dated Jun. 9, 1998 issued in 08/731,499.
US Office Action dated Sep. 13, 1999 issued in 08/731,499.
US Office Action dated Jun. 21, 2000 issued in 08/731,499.
US Office Action dated Mar. 27, 2001 issued in 08/731,499.
US Final Office Action dated Jan. 2, 2002 issued in 08/731,499.
US Final Office Action dated Apr. 9, 2003 issued in 08/731,499.
US Office Action dated Jan. 9, 2004 issued in 08/731,499.
US Office Action dated Oct. 6, 2004 issued in 08/731,499.
US Notice of Allowance and Allowed Claims dated Oct. 19, 2005 issued in 08/731,499.
US Office Action dated Feb. 7, 2000 issued in 08/892,695.
US Office Action dated Nov. 8, 2000 is

Affiliated with

Also associated with

Rating

Genes from the 20q13 amplicon and their uses does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Genes from the 20q13 amplicon and their uses, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Genes from the 20q13 amplicon and their uses will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4036376